QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:RXRX

Recursion Pharmaceuticals (RXRX) Institutional Ownership

$8.43
+0.20 (+2.43%)
(As of 06/5/2023 ET)
Compare
Today's Range
$7.98
$8.76
50-Day Range
$4.56
$9.25
52-Week Range
$4.54
$14.18
Volume
1.96 million shs
Average Volume
1.46 million shs
Market Capitalization
$1.62 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.40

Institutional Ownership Changes (13F Filings) for Recursion Pharmaceuticals (NASDAQ:RXRX)

Current
Institutional Ownership
Percentage
63.62%
Number of
Institutional Buyers
(last 12 months)
106
Total
Institutional Inflows
(last 12 months)
$281.80 M
Number of
Institutional Sellers
(last 12 months)
44
Total
Institutional Outflows
(last 12 months)
$77.35 M
Skip Chart & View Institutional Buying and Selling Data

RXRX Institutional Buying and Selling by Quarter

Get RXRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Recursion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Recursion Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/26/2023ProShare Advisors LLC28,802$0.19M0.0%-11.7%0.015%
5/18/2023Titleist Asset Management LLC35,750$0.24M0.1%N/A0.019%
5/18/2023JPMorgan Chase & Co.309,514$2.06M0.0%+78.6%0.161%
5/18/2023New York State Common Retirement Fund71,090$0.47M0.0%-25.1%0.037%
5/16/2023State Street Corp6,372,515$42.51M0.0%-19.0%3.332%
5/16/2023Squarepoint Ops LLC190,385$1.27M0.0%+172.8%0.100%
5/16/2023Geode Capital Management LLC2,743,484$18.30M0.0%+5.1%1.435%
5/16/2023Balyasny Asset Management L.P.66,986$0.45M0.0%-55.7%0.035%
5/15/2023Cubist Systematic Strategies LLC406,662$2.71M0.0%+154.4%0.213%
5/15/2023Bayesian Capital Management LP24,095$0.16M0.0%-60.8%0.013%
5/15/2023Delphia USA Inc.26,470$0.18M0.2%N/A0.014%
5/15/2023Corton Capital Inc.32,661$0.22M0.2%N/A0.017%
5/15/2023Two Sigma Advisers LP15,400$0.10M0.0%N/A0.008%
5/15/2023Two Sigma Investments LP208,143$1.39M0.0%+184.7%0.109%
5/15/2023Deutsche Bank AG88,660$0.59M0.0%+24.9%0.046%
5/15/2023XTX Topco Ltd48,138$0.32M0.1%+167.2%0.025%
5/12/2023Renaissance Technologies LLC415,561$2.77M0.0%+114.3%0.217%
5/12/2023BlackRock Inc.10,631,857$70.91M0.0%-0.3%5.560%
5/12/2023Bank of America Corp DE557,010$3.72M0.0%+32.0%0.291%
5/12/2023HRT Financial LP168,377$1.12M0.0%N/A0.088%
5/12/2023UBS Group AG168,935$1.13M0.0%-53.3%0.088%
5/12/2023Dark Forest Capital Management LP52,267$0.35M0.1%+7,552.6%0.027%
5/12/2023Dimensional Fund Advisors LP697,285$4.65M0.0%+267.1%0.365%
5/12/2023ProShare Advisors LLC28,802$0.19M0.0%-11.7%0.015%
5/12/2023Profund Advisors LLC71,224$0.48M0.0%N/A0.037%
5/12/2023Platinum Investment Management Ltd.2,770,451$18.48M0.6%+2.2%1.449%
5/11/2023FMR LLC4,755,461$31.72M0.0%+6.5%2.487%
5/11/2023ExodusPoint Capital Management LP31,137$0.21M0.0%N/A0.016%
5/11/2023Rhumbline Advisers209,878$1.40M0.0%+2.1%0.110%
5/11/2023Citigroup Inc.688,225$4.59M0.0%+195.6%0.360%
5/11/2023E Fund Management Co. Ltd.21,417$0.14M0.0%-21.0%0.011%
5/11/2023Skandinaviska Enskilda Banken AB publ 48,200$0.32M0.0%N/A0.025%
5/10/2023Credit Suisse AG1,582,373$10.55M0.0%+0.4%0.827%
5/10/2023Swiss National Bank117,600$0.78M0.0%-1.7%0.061%
5/10/2023Connor Clark & Lunn Investment Management Ltd.227,892$1.52M0.0%+58.2%0.119%
5/9/2023Principal Financial Group Inc.38,945$0.26M0.0%+12.9%0.020%
5/9/2023Tower Research Capital LLC TRC 14,944$100K0.0%+550.0%0.008%
5/9/2023Bank of New York Mellon Corp529,157$3.53M0.0%+4.7%0.277%
5/8/2023Mitsubishi UFJ Kokusai Asset Management Co. Ltd.20,779$0.14M0.0%+10.9%0.011%
5/4/2023Barclays PLC188,222$1.26M0.0%-36.5%0.098%
5/4/2023Mirae Asset Global Investments Co. Ltd.84,859$0.57M0.0%+20.1%0.044%
5/3/2023Jump Financial LLC129,541$0.86M0.0%N/A0.068%
5/3/2023Nikko Asset Management Americas Inc.501,977$3.30M0.0%+10.4%0.262%
5/3/2023Baillie Gifford & Co.25,135,530$167.65M0.2%+1.3%13.144%
5/2/2023Amalgamated Bank14,529$97K0.0%-18.5%0.008%
5/1/2023CWM LLC6,145$41K0.0%+1,888.7%0.003%
4/28/2023SG Americas Securities LLC55,010$0.37M0.0%+96.3%0.029%
4/27/2023Sumitomo Mitsui Trust Holdings Inc.501,977$3.35M0.0%+10.4%0.262%
4/25/2023Foundations Investment Advisors LLC21,161$0.14M0.0%+27.0%0.011%
4/20/2023Accel Wealth Management6,100$41K0.0%N/A0.003%
4/17/2023ARK Investment Management LLC3,576,862$23.86M0.2%+15.4%1.870%
2/22/2023Teachers Retirement System of The State of Kentucky174,435$1.35M0.0%+6.1%0.092%
2/16/2023Alliancebernstein L.P.390,605$3.01M0.0%-87.9%0.206%
2/15/2023Jane Street Group LLC27,093$0.21M0.0%-47.6%0.014%
2/15/2023Lazard Asset Management LLC163,909$1.26M0.0%-46.1%0.086%
2/15/2023State of Wisconsin Investment Board46,181$0.36M0.0%-36.3%0.024%
2/15/2023Schonfeld Strategic Advisors LLC81,204$0.63M0.0%-30.6%0.043%
2/15/2023Squarepoint Ops LLC69,800$0.54M0.0%N/A0.037%
2/15/2023Laurion Capital Management LP4,825,735$37.21M0.2%+5.2%2.546%
2/15/2023Legal & General Group Plc93,970$0.73M0.0%+5.0%0.050%
2/15/2023Millennium Management LLC695,373$5.36M0.0%+190.5%0.367%
2/15/2023Morgan Stanley333,171$2.57M0.0%+20.7%0.176%
2/15/2023Norges Bank4,371,313$33.70M0.0%N/A2.306%
2/15/2023E Fund Management Co. Ltd.27,111$0.21M0.0%+128.6%0.014%
2/15/2023Alps Advisors Inc.123,165$0.95M0.0%+36.6%0.065%
2/14/2023Vident Investment Advisory LLC13,581$0.11M0.0%+16.6%0.007%
2/14/2023Price T Rowe Associates Inc. MD75,919$0.59M0.0%+109.7%0.040%
2/14/2023Amundi7,189$57K0.0%+69.6%0.004%
2/14/2023Alpine Global Management LLC15,533$0.12M0.0%N/A0.008%
2/14/2023Two Sigma Investments LP73,103$0.56M0.0%N/A0.039%
2/13/2023Platinum Investment Management Ltd.2,710,339$20.90M0.8%+20.4%1.430%
2/13/2023Charles Schwab Investment Management Inc.984,681$7.59M0.0%+8.9%0.519%
2/13/2023Deutsche Bank AG70,973$0.55M0.0%+22.2%0.037%
2/13/2023Nikko Asset Management Americas Inc.454,522$3.50M0.1%-7.4%0.240%
2/13/2023Barclays PLC296,600$2.29M0.0%+164.3%0.156%
2/13/2023Renaissance Technologies LLC193,900$1.50M0.0%+1,175.7%0.102%
2/13/2023The Manufacturers Life Insurance Company 55,778$0.43M0.0%+2.7%0.029%
2/13/2023Credit Suisse AG1,575,590$12.15M0.0%+0.7%0.831%
2/13/2023Geode Capital Management LLC2,609,948$20.12M0.0%+11.9%1.377%
2/13/2023GSA Capital Partners LLP22,603$0.17M0.0%N/A0.012%
2/13/2023JPMorgan Chase & Co.173,336$1.34M0.0%-4.3%0.091%
2/13/2023Artal Group S.A.960,204$7.40M0.4%+113.4%0.507%
2/10/2023Bank of America Corp DE421,864$3.25M0.0%+112.1%0.223%
2/10/2023Schroder Investment Management Group159,964$1.23M0.0%+47.0%0.084%
2/10/2023Connor Clark & Lunn Investment Management Ltd.144,013$1.11M0.0%N/A0.076%
2/10/2023Aigen Investment Management LP20,250$0.16M0.0%N/A0.011%
2/9/2023Hamilton Lane Advisors LLC96,474$0.74M0.3%+72.7%0.051%
2/9/2023First Trust Advisors LP241,147$1.86M0.0%+86.3%0.127%
2/9/2023Dimensional Fund Advisors LP189,928$1.46M0.0%N/A0.100%
2/9/2023Principal Financial Group Inc.34,483$0.27M0.0%+4.9%0.018%
2/9/2023Citigroup Inc.232,827$1.80M0.0%+44.1%0.123%
2/8/2023UBS Group AG361,895$2.79M0.0%+1,859.9%0.191%
2/8/2023Swiss National Bank119,600$0.92M0.0%+2.7%0.063%
2/8/2023Russell Investments Group Ltd.131,956$1.02M0.0%-2.3%0.070%
2/8/2023Dakota Wealth Management13,438$0.10M0.0%-50.0%0.007%
2/7/2023LPL Financial LLC45,860$0.35M0.0%+9.8%0.024%
2/7/2023Handelsbanken Fonder AB18,800$0.15M0.0%+41.4%0.010%
2/7/2023Mitsubishi UFJ Kokusai Asset Management Co. Ltd.18,733$0.14M0.0%N/A0.010%
2/6/2023Daiwa Securities Group Inc.6,903$53K0.0%+1,029.8%0.004%
2/6/2023Jackson Creek Investment Advisors LLC77,011$0.59M0.3%N/A0.041%
(Data available from 1/1/2016 forward)













RXRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RXRX shares?

During the previous two years, 167 institutional investors and hedge funds held shares of Recursion Pharmaceuticals. The most heavily invested institutionals were Baillie Gifford & Co. ($167.65M), Vanguard Group Inc. ($89.17M), BlackRock Inc. ($70.91M), Kinnevik AB publ ($59.01M), Harvard Management Co. Inc. ($55.09M), Mic Capital Partners Public US IM LLC ($50.69M), and State Street Corp ($42.51M).Learn more on RXRX's institutional investors.

What percentage of Recursion Pharmaceuticals stock is owned by institutional investors?

63.62% of Recursion Pharmaceuticals stock is owned by institutional investors. Learn more on RXRX's institutional investor holdings.

Which institutional investors have been buying Recursion Pharmaceuticals stock?

Of the 155 institutional investors that purchased Recursion Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baillie Gifford & Co. ($25.66M), Kinnevik AB publ ($7.65M), State Street Corp ($6.03M), Vanguard Group Inc. ($4.57M), Norges Bank ($4.37M), Laurion Capital Management LP ($4.16M), and ARK Investment Management LLC ($4.08M).

How much institutional buying is happening at Recursion Pharmaceuticals?

Institutional investors have bought a total of 96,049,595 shares in the last 24 months. This purchase volume represents approximately $2.16B in transactions.

Which Recursion Pharmaceuticals major shareholders have been selling company stock?

Of the 57 institutional investors that sold Recursion Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($4.24M), Alliancebernstein L.P. ($3.21M), Two Sigma Ventures LP ($0.90M), ARK Investment Management LLC ($0.72M), Price T Rowe Associates Inc. MD ($0.54M), Baillie Gifford & Co. ($0.53M), and Massachusetts Financial Services Co. MA ($0.47M).

How much institutional selling is happening at Recursion Pharmaceuticals?

Institutional investors have sold a total of 13,876,813 shares in the last 24 months. This volume of shares sold represents approximately $119.55M in transactions.


This page (NASDAQ:RXRX) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -